Clinical evaluation and mechanism study on the synergistic treatment and rehabilitation of diabetic macular edema by Chinese and Western medicine

Eye Hospital, China Academy of Chinese Medical Sciences0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•Synergistic Chinese and Western medicine treatment program, Synergistic Chinese and Western medicine low vision rehabilitation program.
•(1) Those with poorly cleared refractive interstitium and difficulty in fundus observation.
•(2) Those who have already undergone vitreous cavity injection of anti-VEGF or hormonal drugs, gridded photocoagulation, local photocoagulation, or total retinal photocoagulation within 3 months after any one or more of these treatment modalities.
•(3) Those with combined fundus disease such as glaucoma, retinal vein obstruction, uveitis, or optic nerve disease.
•(4) Patients with combined severe cardiovascular, hepatic and hematopoietic system diseases and diabetic nephropathy with renal failure; HBA1c = 10% and liver and kidney function test results exceeding 1.5 times normal
•(5) Patients with combined serious life-threatening primary diseases and psychiatric disorders
•(6) Pregnant or lactating women.
•(7) Those who are participating in clinical trials of other drugs or are taking drugs that may affect the clinical evaluation of this study.
•(8) Inability to cooperate during the examination and to adhere to the follow-up fundus examination.

•Synergistic Chinese and Western medicine treatment program, Synergistic Chinese and Western medicine low vision rehabilitation program.
•(1) Those with poorly cleared refractive interstitium and difficulty in fundus observation.
•(2) Those who have already undergone vitreous cavity injection of anti-VEGF or hormonal drugs, gridded photocoagulation, local photocoagulation, or total retinal photocoagulation within 3 months after any one or more of these treatment modalities.
•(3) Those with combined fundus disease such as glaucoma, retinal vein obstruction, uveitis, or optic nerve disease.
•(4) Patients with combined severe cardiovascular, hepatic and hematopoietic system diseases and diabetic nephropathy with renal failure; HBA1c = 10% and liver and kidney function test results exceeding 1.5 times normal
•(5) Patients with combined serious life-threatening primary diseases and psychiatric disorders
•(6) Pregnant or lactating women.
•(7) Those who are participating in clinical trials of other drugs or are taking drugs that may affect the clinical evaluation of this study.
•(8) Inability to cooperate during the examination and to adhere to the follow-up fundus examination.

发起方

Eye Hospital, China Academy of Chinese Medical Sciences